Document Detail

Establishment and characterization of a new human gallbladder carcinoma cell line.
MedLine Citation:
PMID:  22843894     Owner:  NLM     Status:  In-Data-Review    
BACKGROUND: Prognosis for patients with gallbladder carcinoma (GBC) is poor and the standard treatment for GBC has not yet been established.
MATERIALS AND METHODS: We established the human GBC cell line TYGBK-1, from a patient with papillary, tubular adenocarcinoma.
RESULTS: The doubling time was 48 hours. This cell line has a missense mutation of p53 and no mutation of the K-RAS gene. This cell line was transplantable to nude mice. We characterized the sensitivity of TYGBK-1 to gemcitabine. We also examined the association of two gemcitabine-related genes (deoxycytidine kinase, dCK, and Hu antigen R, HuR). Among four GBC cell lines (TYGBK-1, NOZ, G-415, TGBC2TKB), TYGBK-1 and NOZ exhibited sensitivity to gemcitabine. Furthermore, these cells expressed both dCK and HuR mRNA, rather than gemcitabine-resistant cells.
CONCLUSION: The newly established GBC cell line TYGBK-1, may represent an effective tool for development of chemotherapeutic treatment for GBC.
Shinichi Sekine; Yutaka Shimada; Takuya Nagata; Makoto Moriyama; Testuya Omura; Isaku Yoshioka; Ryouta Hori; Koushi Matsui; Shigeaki Sawada; Tomoyuki Okumura; Toru Yoshida; Kazuhiro Tsukada
Related Documents :
154524 - On the reduced intercellular adhesiveness of virally transformed bhk21 cells.
9249004 - Neutral glycosphingolipids induce cell-cell aggregation of a variety of hematopoietic c...
22713244 - Activity of the selective iκb kinase inhibitor bms-345541 against t-cell acute lymphob...
22767244 - Microtrap electrode devices for single cell trapping and impedance measurement.
22713594 - Pharmacoperone in3 enhances the apoptotic effect of leuprolide in prostate cancer cells...
14511674 - Involvement of multidrug resistance-associated proteins in regulating cellular levels o...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  32     ISSN:  1791-7530     ISO Abbreviation:  Anticancer Res.     Publication Date:  2012 Aug 
Date Detail:
Created Date:  2012-07-30     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  Greece    
Other Details:
Languages:  eng     Pagination:  3211-8     Citation Subset:  IM    
Department of Surgery and Science, University of Toyama, 2630 Sugitani, Toyama-city, Toyama, 930-0194, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overexpression of Epstein-Barr Virus-encoded microRNA-BART7 in Undifferentiated Nasopharyngeal Carci...
Next Document:  Glyoxalase I (GLO1) is Up-regulated in Pancreatic Cancerous Tissues Compared with Related Non-cancer...